6 "inflammatory bowel diseases" clinical trials found.
-
Clinical Outcomes of Medications Post Anti-TNF: Researching Effectiveness in Pediatric IBD
The purpose of the study is to compare the clinical effectiveness and safety of newer inflammatory bowel disease (IBD) medications in anti-tumor necrosis factor (TNF ...Phase N/A
Non-Interventional
-
Building a multidisciplinary transition readiness clinic for adolescents and young adults with inflammatory bowl disease using the TRAQ
The purpose of this study is to evaluate a structured transition program for adolescents and young adults with inflammatory bowel disease (IBD) at the NYU ...Phase N/A Non-Interventional
-
CA45905: Phase III randomized double-blind multi-center study evaluating PK PD immunogenicity safety and efficacy of RO7790121 induction and maintenance therapy in children (2 17 years) with moderately to severely active ulcerative colitis.
This study is to assess the efficacy and safety of RO7790121 (formerly PF-06480605 and RVT-3101) in pediatric patients with moderately to severely active ulcerative colitis ...Phase
Interventional
-
ICONIC-UC: Phase 3 randomized double-blind placebo-controlled study in adults and open-label in adolescents to evaluate efficacy and safety of icotrokinra for induction and maintenance in moderate to severe ulcerative colitis.
The purpose of this study is to learn more about a study medicine called icotrokinra and to find out if it is safe and helps ...Phase
Interventional
-
C5041018 A PHASE 2 OPEN LABEL SINGLE ARM STUDY TO EVALUATE THE EFFICACY PHARMACOKINETICS AND SAFETY OF ETRASIMOD IN PEDIATRIC PARTICIPANTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
The purpose of this study is to assess the effects of the study drug, etrasimod, for treating pediatric ulcerative colitis (UC) participants. Participants will take ...Phase
Interventional
-
CP45906: SIBERITE-PEDS Phase III randomized double-blind multi-center study evaluating PK PD immunogenicity safety and efficacy of RO7790121 induction and maintenance therapy in children 2 17 years with moderate to severe Crohn s disease.
The purpose of this study is to assess the efficacy and safety of RO7790121 (formerly PF-06480605 and RVT-3101) in pediatric patients with moderately to severely ...Phase
Interventional
